Martin Sorrell, CEO of WPP, explains why he is not worried about the terms of doing business in the China following news that Beijing is reviewing drafts of its first counterterrorism law.» Read More
Gemma Godfrey, head of investment strategy at Brooks Macdonald Asset Management, gives three reasons why European equities look good in the long term, especially compared with the U.S.
John W. Krey, international investment analyst at S&P Investment Advisory Services, says that with retail sales improving in the euro zone, investors are showing greater confidence in the region.
How does the cease-fire between Russia and Ukraine impact investors and businesses? Robert Buckland, chief global equity strategist at Citi Investment Research, weighs in.
Sam Walsh, CEO of Rio Tinto, says now is not the time to be buying distressed assets, for his company.
Brian Goldner, Hasbro president & CEO, provides an exclusive look at some brand new toys that haven't hit the shelves yet.
Norsk Hydro reported its best earnings since restructuring in 2007. Eivind Kallevik, CFO at Norsk Hydro, says the operational improvements within the company have helped its results.
Does innovation really deliver for investors? Mark Payne, author of "How to Kill a Unicorn," says that innovation is a prominent component affecting how a company is perceived - big or small.
Is Samsung losing its mojo? Alex Wood, editor-in-chief at Tech City News, says Samsung is suffering a fall in sales, as it hasn't managed to keep up with its competitors like Apple; therefore it must diversify.
Christian Hernandez Gallardo, managing partner of White Star Capital says Facebook is now "the federation of platforms" due to its multiple applications.
Massive opportunities still exist in China despite slowing growth there, says Michael Yoshikami.
Jeffrey Sonnenfeld, Yale School of Management, shares his thoughts on the difference between "faux" activist and those that add shareholder value.
Turney Duff, now five years sober, talks about how cocaine crushed his trading skills—and cost him and his firm millions.
Express Scripts chief medical officer Steve Miller, discusses pricing competition in drugs. Express Scripts signed a deal with AbbVie to exclusively carry its hep C drug.
Could we see a bottom to the oil price soon? Henry Dixon, fund manager at GLG, weighs in and says that the oil price is not a "dividend threat" to oil majors.
Here's why Obama's plan to tax overseas profits is a good thing — and it could actually succeed in shutting down tax havens.
CNBC's David Faber provides insight to what appears to be heightened tensions between DuPont and Trian.
Kevin Plank, Under Armour CEO, discusses celebrity endorsement deals, including Tom Brady and competing with Nike.
Wearables will equal apparel one day, says Kevin Plank, Under Armour CEO, discussing his company's digital fitness strategy.
Matt Vella, Time Magazine, shares insights from his in-depth interview with Starbucks' CEO Howard Schultz.
Twitter earnings: Scott Kessler, senior equity analyst at S&P Capital IQ says Twitter has done a great job with global expansion; however the question now is how can Twitter push its brand message and increase monetisation.